p53 and E2f: partners in life and death

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063

Network motifs: theory and experimental approaches

Alon, U. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2102 · Cited by 3,279

Live or let die: the cell's response to p53

Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,231

A microRNA component of the p53 tumour suppressor network

He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692

PUMA, a Novel Proapoptotic Gene, Is Induced by p53

Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315

Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis

Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112

Negative Control of p53 by Sir2α Promotes Cell Survival under Stress

Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081

Tumor spectrum analysis in p53-mutant mice

Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051

Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53

Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042

Suppression of cell cycle progression by Jun dimerization protein (JDP2) involves down-regulation of cyclin A2Preprint

Pan, J., Nakade, K., Huang, Y.-C., Zhu, Z.-W., Masuzaki, S., Hasegawa, H., Murata, T., Yoshiki, A., Yamaguchi, N., Lee, C., et al. (2009) · Nature Precedings · doi:10.1038/onc.2010.355 · Cited by 58

Evidence for a novel anti-apoptotic pathway in human keratinocytes involving the aryl hydrocarbon receptor, E2F1, and checkpoint kinase 1

Frauenstein, K., Sydlik, U., Tigges, J., Majora, M., Wiek, C., Hanenberg, H., Abel, J., Esser, C., Fritsche, E., Krutmann, J., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.102 · Cited by 56

TP53 dysfunction in diffuse large B-cell lymphoma

Lu, T., Young, K. H., Xu, W., & Li, J.-Y. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.006 · Cited by 58

E2F1 Mediated Apoptosis Induced by the DNA Damage Response Is Blocked by EBV Nuclear Antigen 3C in Lymphoblastoid Cells

Saha, A., Lu, J. L., Morizur, L., Upadhyay, S. K., Mahadesh Prasad, A. J., & Robertson, E. S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002573 · Cited by 56

MicroRNA Cancer Regulation

Schmitz, U., Wolkenhauer, O., & Vera, J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1 · Cited by 56

Significant associations between driver gene mutations and DNA methylation alterations across many cancer types

Chen, Y.-C., Gotea, V., Margolin, G., & Elnitski, L. L. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005840 · Cited by 56

Mdm2 and MdmX as Regulators of Gene Expression

Biderman, L., Manley, J. L., & Prives, C. L. (2012) · Genes & Cancer · doi:10.1177/1947601912455331 · Cited by 58

Tumor suppressor p53 cross-talks with TRIM family proteins

Liu, J., Zhang, C., Wang, X., Hu, W., & Feng, Z. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.07.003 · Cited by 57

Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment

Urso, L., Calabrese, F., Favaretto, A. G., Conte, P., & Pasello, G. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.019 · Cited by 54

Regulation of tissue‐ and stimulus‐specific cell fate decisions by p53 in vivo

Jackson, J. G., Post, S. M., & Lozano, G. (2010) · The Journal of Pathology · doi:10.1002/path.2783 · Cited by 55

Emerging Links between E2F Control and Mitochondrial Function

Benevolenskaya, E. V., & Frolov, M. V. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2173 · Cited by 54

Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells.

Seo, H. S., Choi, H. S., Yk, C., Choi, Y. K., Um, J.-Y., Choi, I., Shin, Y. C., & Ko, S.-G. (2011) · PubMed · Cited by 54

Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells

Benedict, B., van Harn, T., Dekker, M., Hermsen, S., Küçükosmanoğlu, A., Pieters, W., Delzenne‐Goette, E., Dorsman, J. C., Petermann, E., Foijer, F., et al. (2018) · eLife · doi:10.7554/elife.37868 · Cited by 54

The Apoptotic Function Analysis of p53, Apaf1, Caspase3 and Caspase7 during the Spermatogenesis of the Chinese Fire-Bellied Newt Cynops orientalis

Wang, D., Hu, J.-R., Wang, L., Hu, Y.-J., Tan, F.-Q., Zhou, H., Shao, J., & Yang, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039920 · Cited by 53

Survival of pancreatic beta cells is partly controlled by a TCF7L2-p53-p53INP1-dependent pathway

Zhou, Y., Zhang, E., Berggreen, C., Jing, X., Osmark, P., Lang, S., Cilio, C., Göransson, O., Groop, L., Renström, E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr454 · Cited by 55

p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma

Hideshima, T., Cottini, F., Nozawa, Y., Seo, H., Ohguchi, H., Samur, M., Cirstea, D. D., Mimura, N., Iwasawa, Y., Richardson, P. G. G., et al. (2017) · Blood · doi:10.1182/blood-2016-09-738500 · Cited by 56

Genomic landscape of salivary gland tumors

Kato, S., Elkin, S. K., Schwaederle, M. C., Tomson, B. N., Helsten, T. L., Carter, J. L., & Kurzrock, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4554 · Cited by 52

Britannin, a sesquiterpene lactone, inhibits proliferation and induces apoptosis through the mitochondrial signaling pathway in human breast cancer cells

Moghadam, M. H., Aghaei, M., Fallahian, F., Jafari, S. M., Dolati, M., Abdolmohammadi, M. H., Hajiahmadi, S., & Esmaeili, S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2744-9 · Cited by 52

New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort

Hoffman, A., Lazar, A. J., Pollock, R. E., & Lev, D. C. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.11.001 · Cited by 52

FOXO Transcription Factors Control E2F1 Transcriptional Specificity and Apoptotic Function

Shats, I., Gatza, M. L., Liu, B., Angus, S. P., You, L., & Nevins, J. R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0453 · Cited by 53

CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond

Chibon, F., Lesluyes, T., Valentin, T., & Guellec, S. L. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22703 · Cited by 55

Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3

Lui, J. C. K., & Baron, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219079110 · Cited by 51

VRK1 interacts with p53 forming a basal complex that is activated by UV‐induced DNA damage

López-Sánchez, I., Valbuena, A., Vázquez-Cedeira, M., Khadake, J., Sanz-García, M., Carrillo-Jiménez, A., & Lazo, P. A. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.01.040 · Cited by 52

KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes

Koh, D.-I., Han, D., Ryu, H., Choi, W., Jeon, B.-N., Kim, M.-K., Kim, Y., Kim, J. Y., Parry, L., Clarke, A. R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318780111 · Cited by 52

miR‑34a and miR‑125b are upregulated in peripheral blood mononuclear cells from patients with type 2 diabetes mellitus

Shen, Y., Xu, H., Pan, X., Wu, W., Wang, H., Yan, L., Zhang, M., Liu, X., Xia, S., & Shao, Q. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5254 · Cited by 51

p16INK4Aand p14ARFTumor Suppressor Pathways Are Deregulated in Malignant Rhabdoid Tumors

Venneti, S., Le, P., Martínez, D., Eaton, K. W., Shyam, N., Jordan‐Sciutto, K. L., Pawel, B., Biegel, J. A., & Judkins, A. R. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822146ca · Cited by 50

Changes in Mouse Uterine Transcriptome in Estrus and Proestrus1

Yip, K. S., Suvorov, A., Connerney, J., Lodato, N. J., & Waxman, D. J. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.112.107334 · Cited by 49

Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression

Zhou, Y., Nakajima, R., Shirasawa, M., Fikriyanti, M., Zhao, L., Iwanaga, R., Bradford, A. P., Kurayoshi, K., Araki, K., & Ohtani, K. (2023) · Biology · doi:10.3390/biology12121511 · Cited by 52

EWS-FLI1 employs an E2F switch to drive target gene expression

Schwentner, R., Papamarkou, T., Kauer, M. O., Stathopoulos, V., Yang, F., Bilke, S., Meltzer, P. S., Girolami, M., & Kovar, H. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv123 · Cited by 49

Cell-Cycle Regulators and Cell Death in Immunity

Zebell, S. G., & Dong, X. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.10.001 · Cited by 48

Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation

Kumari, A., Iwasaki, T., Pyndiah, S., Cassimere, E. K., Palani, C. D., & Sakamuro, D. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.146 · Cited by 50

Nanog regulates molecules involved in stemness and cell cycle‐signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells

Choi, S., Choi, J.-H., Park, C., Ahn, C., Hong, S. J., & Lim, D. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24076 · Cited by 52

Keratin23 (KRT23) Knockdown Decreases Proliferation and Affects the DNA Damage Response of Colon Cancer Cells

Birkenkamp‐Demtröder, K., Hahn, S. A., Mansilla, F., Thorsen, K., Maghnouj, A., Christensen, R., Øster, B., & Orntoft, T. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073593 · Cited by 49

Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics

Jacobson, O., & Chen, X. S. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007625 · Cited by 48

Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells

Wang, J., Wu, P., Chen, P. C.-H., Lee, C.-W., Chen, W., & Hung, S. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0226 · Cited by 52

MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating E2F1, E2F3, and Caspase-3

Han, R., Chen, X., Li, Y., Zhang, S., Li, R., & Lu, L. (2019) · Cancer Management and Research · doi:10.2147/cmar.s202664 · Cited by 48

MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53

Klein, A. M., Biderman, L., Tong, D., Alaghebandan, B., Plumber, S. A., Mueller, H. S., van Vlimmeren, A. E., Katz, C., & Prives, C. L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102420118 · Cited by 48

The Retinoblastoma Protein Is Essential for Survival of Postmitotic Neurons

Andrusiak, M. G., Vandenbosch, R., Park, D. S., & Slack, R. S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1912-12.2012 · Cited by 47

MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells

Zheng, S., Sun, P., Wang, J.-P., Liu, Y., Gong, W., & Liu, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2752 · Cited by 47

E2F1 transactivates IQGAP3 and promotes proliferation of hepatocellular carcinoma cells through IQGAP3-mediated PKC-alpha activation.

Lin, M., Liu, Y., Ding, X., Ke, Q., Shi, J., Ma, Z., Gu, H., Wang, H., Zhang, C., Yang, C., et al. (2019) · Europe PMC (PubMed Central) · Cited by 46

p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb–Hdm2 interaction and apoptosis

Delston, R. B., Matatall, K. A., Sun, Y., Onken, M. D., & Harbour, J. W. (2010) · Oncogene · doi:10.1038/onc.2010.442 · Cited by 49

Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells

Zhang, H., Zhang, D., Zha, Z., & Hu, C. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.015 · Cited by 45

The retinoblastoma protein (Rb) as an anti-apoptotic factor: expression of Rb is required for the anti-apoptotic function of BAG-1 protein in colorectal tumour cells

Collard, T. J., Urban, B. C., Patsos, H. A., Hague, A., Townsend, P. A., Paraskeva, C., & Williams, A. C. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.142 · Cited by 45

Expression and Role of p53 in the Retina

Vuong, L., Conley, S. M., & Al‐Ubaidi, M. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8909 · Cited by 45

The regulation of radiosensitivity by p53 and its acetylation

Zhang, J., Shen, L., & Sun, L. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.015 · Cited by 45

p53 and Translation Attenuation Regulate Distinct Cell Cycle Checkpoints during Endoplasmic Reticulum (ER) Stress

Thomas, S. E., Malzer, E., Ordóñez, A., Dalton, L. E., Wout, E. F. A. V. ’., Liniker, E., Crowther, D. C., Lomas, D. A., & Marciniak, S. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.424655 · Cited by 45

The Enigma of miRNA Regulation in Cancer

Pradhan, A. K., Emdad, L., Das, S. K., Sarkar, D., & Fisher, P. B. (2017) · Advances in cancer research · doi:10.1016/bs.acr.2017.06.001 · Cited by 44

Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death

Hauck, L., Stanley-Hasnain, S., Fung, A., Grothe, D., Rao, V., Mak, T. W., & Billia, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189861 · Cited by 46

Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma

Oehl, K., Vrugt, B., Wagner, U., Kirschner, M. B., Meerang, M., Weder, W., Felley‐Bosco, E., Wollscheid, B., Bankov, K., Demes, M. C., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4037 · Cited by 44

CDK4, CDK6/cyclin-D1 Complex Inhibition and Radiotherapy for Cancer Control: A Role for Autophagy

Nardone, V., Barbarino, M., Angrisani, A., Correale, P., Pastina, P., Cappabianca, S., Reginelli, A., Mutti, L., Miracco, C., Giannicola, R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168391 · Cited by 44

The E2F1-miRNA Cancer Progression Network

Knoll, S., Emmrich, S., & Pützer, B. M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1_8 · Cited by 42

E2F1 controls germ cell apoptosis during the first wave of spermatogenesis

Rotgers, E., Nurmio, M., Pietilä, E., Cisneros-Montalvo, S., & Toppari, J. (2015) · Andrology · doi:10.1111/andr.12090 · Cited by 42

Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis

Chen, H.-Z., Li, L., Wang, W.-J., Du, X.-D., Wen, Q., He, J., Zhao, B.-X., Li, G.-D., Zhou, W., Xia, Y. F., et al. (2011) · Oncogene · doi:10.1038/onc.2011.463 · Cited by 42

E2F1 suppresses cardiac neovascularization by down-regulating VEGF and PlGF expression

Wu, M., Zhou, J., Cheng, M., Boriboun, C., Biyashev, D., Wang, H., Mackie, A. R., Thorne, T. E., Chou, J. C., Wu, Y., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu222 · Cited by 41

Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB

Hernández‐Monge, J., Rousset-Roman, A. B., Medina‐Medina, I., & Olivares‐Illana, V. (2016) · Genes & Cancer · doi:10.18632/genesandcancer.120 · Cited by 41

HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4+ T cells

Kawatsuki, A., Yasunaga, J., Mitobe, Y., Green, P. L., & Matsuoka, M. (2016) · Oncogene · doi:10.1038/onc.2015.510 · Cited by 45

Primate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer's disease

Zhang, C., Lu, J., Liu, B., Cui, Q., & Wang, Y. (2016) · Aging · doi:10.18632/aging.100887 · Cited by 41

The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21

Yousefi, B., Rahmati, M., & Ahmadi, Y. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.01.063 · Cited by 39

Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway

Lv, H., Liu, R., Fu, J., Yang, Q., Shi, J., Chen, P., Ji, M., Shi, B., & Hou, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.947203 · Cited by 39

Transcription Factor NF-Y Induces Apoptosis in Cells Expressing Wild-Type p53 through E2F1 Upregulation and p53 Activation

Gurtner, A., Fuschi, P., Martelli, F., Manni, I., Artuso, S., Simonte, G., Ambrosino, V., Antonini, A., Folgiero, V., Falcioni, R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0721 · Cited by 40

MDM2promoter SNP285 and SNP309; phylogeny and impact on cancer risk

Knappskog, S., & Lønning, P. E. (2011) · Oncotarget · doi:10.18632/oncotarget.243 · Cited by 39

Impact of EBV Essential Nuclear Protein EBNA-3C on B-Cell Proliferation and Apoptosis

Saha, A., & Robertson, E. S. (2013) · Future Microbiology · doi:10.2217/fmb.12.147 · Cited by 40

DGKζ under stress conditions: “To be nuclear or cytoplasmic, that is the question”

Goto, K., Tanaka, T., Nakano, T., Okada, M., Hozumi, Y., Topham, M. K., & Martelli, A. M. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.08.007 · Cited by 39

Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients

Lucas, C. M., Harris, R. J., Holcroft, A. K., Scott, L. J., Carmell, N., McDonald, E., Polydoros, F., & Clark, R. E. (2015) · Leukemia · doi:10.1038/leu.2015.71 · Cited by 37

miR‐203 Is a Direct Transcriptional Target of E2F1 and Causes G1 Arrest in Esophageal Cancer Cells

Zhang, K., Dai, L., Zhang, B., Xu, X., Shi, J., Fu, L., Chen, X., Li, J., & Bai, Y. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24821 · Cited by 37

Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway

Chen, J., Li, W., Cui, K., Ji, K., Xu, S., & Xu, Y. (2018) · Oncogene · doi:10.1038/s41388-018-0331-z · Cited by 37

Decoding Gastric Cancer: Machine Learning Insights Into The Significance Of COMMDs Family In Immunotherapy And Diagnosis

Wan, R., Pan, L., Wang, Q., Shen, G., Guo, R., Qin, Y., Huang, X., Wang, R., & Fan, X. (2024) · Journal of Cancer · doi:10.7150/jca.94360 · Cited by 36

Molecular Pathways: Harnessing E2F1 Regulation for Prosenescence Therapy in p53-Defective Cancer Cells

Laine, A., & Westermarck, J. K. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1942 · Cited by 41

EZH2 Regulates the Developmental Timing of Effectors of the Pre–Antigen Receptor Checkpoints

Jacobsen, J. A., Woodard, J., Mandal, M., Clark, M. R., Bartom, E. T., Sigvardsson, M., & Kee, B. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700319 · Cited by 39

The Canonical E2Fs Are Required for Germline Development in Arabidopsis

Yao, X., Yang, H., Zhu, Y.-X., Xue, J., Wang, T., Song, T., Yang, Z., & Wang, S. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.00638 · Cited by 36

Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration

Rivera, F. J. S., Ryan, J. A., Soto‐Feliciano, Y. M., Beytagh, M. C., Xuan, L. L., Feldser, D. M., Hemann, M. T., Zamudio, J. R., Dimitrova, N., Letai, A. G., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019740118 · Cited by 36

Contracting the ‘mus cells’– does down‐sizing suit us for diving into the memory pool?

Kurtuluş, S., Tripathi, P., Opferman, J. T., & Hildeman, D. A. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00920.x · Cited by 35

Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia

Jorgez, C. J., Wilken, N., Addai, J. B., Newberg, J. Y., Vangapandu, H. V., Pastuszak, A. W., Mukherjee, S., Rosenfeld, J. A., Lipshultz, L. I., & Lamb, D. J. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.09.021 · Cited by 38

Novel Insights into Chk1 Regulation by Phosphorylation

Goto, H., Kasahara, K., & Inagaki, M. (2014) · Cell Structure and Function · doi:10.1247/csf.14017 · Cited by 37

E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53

Bajaj, S., Alam, S. K., Roy, K. S., Datta, A., Nath, S., & Roychoudhury, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731398 · Cited by 35

Transcriptional networks orchestrating programmed cell death during plant development

Cubría-Radío, M., & Nowack, M. K. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.10.006 · Cited by 35

Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: A novel mechanism for host-microbe survival and HCC development in liver cirrhosis

Dash, S., Aydın, Y., & Wu, T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.07.015 · Cited by 36

Cytoplasmic localization of DGKζ exerts a protective effect against p53-mediated cytotoxicity

Tanaka, T., Okada, M., Hozumi, Y., Tachibana, K., Kitanaka, C., Hamamoto, Y., Martelli, A. M., Topham, M. K., Iino, M., & Goto, K. (2013) · Journal of Cell Science · doi:10.1242/jcs.118711 · Cited by 36

Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells

Kang, D. W., Lee, S., Hwang, W. C., Lee, B. H., Choi, Y.-S., Suh, Y., Choi, K., & Min, D. S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3032 · Cited by 35

SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B

Yu, Z., Sun, Y., She, X., Wang, Z., Chen, S., Deng, Z., Zhang, Y., Liu, Q., Liu, Q., Zhao, C., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0483-2 · Cited by 35

Loss of dE2F compromises mitochondrial function

Ambrus, A. M., Islam, A. B. M. M. K., Holmes, K. B., Moon, N. S., Lopez-Bigas, N., Benevolenskaya, E. V., & Frolov, M. V. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.10.002 · Cited by 34

Reciprocal regulation of p53 and NF-κB by diacylglycerol kinase ζ

Tanaka, T., Tsuchiya, R., Hozumi, Y., Nakano, T., Okada, M., & Goto, K. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.09.009 · Cited by 34

Triple-negative breast cancer: new perspectives for novel therapies

Mahamodhossen, Y. A., Liu, W., & Zhou, R. (2013) · Medical Oncology · doi:10.1007/s12032-013-0653-1 · Cited by 34

Induction of p21CIP1 Protein and Cell Cycle Arrest after Inhibition of Aurora B Kinase Is Attributed to Aneuploidy and Reactive Oxygen Species

Kumari, G., Ulrich, T., Krause, M., Finkernagel, F., & Gaubatz, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.555060 · Cited by 35

ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response

Jang, E. R., Choi, J. D., Park, M. A., Jeong, G., Cho, H., & Lee, J. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.3.020 · Cited by 34

Targeting LINC00673 expression triggers cellular senescence in lung cancer

Roth, A., Boulay, K., Groß, M., Polycarpou‐Schwarz, M., Mallette, F. A., Regnier, M., Bida, O., Ginsberg, D., Warth, A., Schnabel, P. A., et al. (2018) · RNA Biology · doi:10.1080/15476286.2018.1553481 · Cited by 33

MicroRNA‐205‐5p targets E2F1 to promote autophagy and inhibit pulmonary fibrosis in silicosis through impairing SKP2‐mediated Beclin1 ubiquitination

Qian, Q., Ma, Q., Wang, B., Qian, Q., Zhao, C., Feng, F., & Dong, X. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16825 · Cited by 33

Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway

Tsai, H., Wei, K., Chen, P., Huang, C.-Y., Chen, K., Lin, Y.-J., Cheng, H.-W., Chen, Y.-R., & Wang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.722754 · Cited by 33

RBM38 Is a Direct Transcriptional Target of E2F1 that Limits E2F1-Induced Proliferation

Feldstein, O., Ben‐Hamo, R., Bashari, D., Efroni, S., & Ginsberg, D. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0331 · Cited by 34

EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation

Pei, Y., Banerjee, S., Sun, Z., Jha, H. C., Saha, A., & Robertson, E. S. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005844 · Cited by 34

Combined effects of E2F1 and E2F2 polymorphisms on risk and early onset of squamous cell carcinoma of the head and neck

Lü, M., Liu, Z., Yu, H., Wang, L., Li, G., Sturgis, E. M., Johnson, D. G., & Wei, Q. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21882 · Cited by 32

Integrating Bayesian variable selection with Modular Response Analysis to infer biochemical network topology

Santra, T., Kölch, W., & Kholodenko, B. Ν. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-57 · Cited by 32

Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy

Geybels, M. S., Wright, J. L., Bibikova, M. V., Klotzle, B., Fan, J., Zhao, S., Feng, Z., Ostrander, E. A., Lin, D. W., Nelson, P. S., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0260-z · Cited by 32

BTK inhibitors synergise with 5‐FU to treat drug‐resistant TP53‐null colon cancers

Lavitrano, M., Ianzano, L., Bonomo, S., Cialdella, A., Cerrito, M. G., Pisano, F., Missaglia, C., Giovannoni, R., Romano, G., McLean, C. M., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5347 · Cited by 32

Association rule mining of cellular responses induced by metal and metal oxide nanoparticles

Liu, R., France, B., George, S., Ralló, R., Zhang, H., Xia, T., Nel, A. E., Bradley, K. A., & Cohen, Y. (2013) · The Analyst · doi:10.1039/c3an01409f · Cited by 32

Role of EBNA-3 Family Proteins in EBV Associated B-cell Lymphomagenesis

Bhattacharjee, S., Roy, S. G., Bose, P., & Saha, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00457 · Cited by 33

Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low‐risk, nontraditional patients

Gingerich, M. A., Smith, J. D., Michmerhuizen, N. L., Ludwig, M., Devenport, S. N., Matovina, C. N., Brenner, J. C., & Chinn, S. B. (2018) · Head & Neck · doi:10.1002/hed.25057 · Cited by 33

Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis

Zane, L. K., Yasunaga, J., Mitagami, Y., Yedavalli, V. R. K., Tang, S.-W., Chen, C., Ratner, L., Lu, X., & Jeang, K.-T. (2012) · Retrovirology · doi:10.1186/1742-4690-9-114 · Cited by 34

E2F1-dependent oncogenic addiction of melanoma cells to MDM2

Verhaegen, M. E., Chęcińska, A., Riblett, M., Wang, S., & Soengas, M. S. (2011) · Oncogene · doi:10.1038/onc.2011.277 · Cited by 31

Tumor Milieu Controlled by RB Tumor Suppressor

Kitajima, S., Li, F., & Takahashi, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072450 · Cited by 30

Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression

Zhou, Y., Nakajima, R., Shirasawa, M., Fikriyanti, M., Zhao, L., Iwanaga, R., Bradford, A. P., Kurayoshi, K., Araki, K., & Ohtani, K. (2023) · Biology · doi:10.3390/biology12121511 · Cited by 52

Role of the RB Tumor Suppressor in Cancer

Yamasaki, L. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48158-8_9 · Cited by 88

E2F and p53 make a nice couple: converging pathways in apoptosis

Dynlacht, B. D. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401612 · Cited by 10

E2F and the molecular mechanisms of early cell-cycle control

Thangue, N. B. L. (1996) · Biochemical Society Transactions · doi:10.1042/bst0240054 · Cited by 72

Integration of the PRB and P53 Cell Cycle Control Pathways

Stewart, C. L., Soria, A. M., & Hamel, P. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010615822317 · Cited by 27